BioCentury
ARTICLE | Company News

Xtent cardiovascular news

August 10, 2009 7:00 AM UTC

Xtent filed a certificate of dissolution in Delaware, effective Aug. 27. The company's Custom NX DES System, a biolimus A9-eluting customizable stent system, received CE Mark approval in the EU to tre...